Omada Teams Up With Lilly to Make Weight‑Loss Drugs Easier for Workplaces

Omada Health has joined forces with Eli Lilly’s Employer Connect program, stepping in as an independent manager of a new weight‑loss medication pathway. The partnership lets employers give employees access to the GLP‑1 Care Track, which covers medical checks, prescriptions and ongoing drug monitoring. This new route adds to Omada’s existing pharmacy‑benefit and cash‑pay options, giving employers a clearer way to bundle medication with lifestyle coaching. By working inside Lilly’s system, Omada can offer a transparent price for Zepbound® and let companies set predictable contribution levels. The result is a single, coordinated program that covers both the drug and the support needed to keep people on track. Employers can now choose from three main options: pharmacy‑benefit manager, direct‑to‑employer or cash‑pay, giving them flexibility to match coverage design with the people they serve.The move comes as demand for anti‑obesity medicines grows and budgets tighten. Surveys of over 3, 000 patients who are not part of Omada show many want more time with their doctors and extra help with diet and exercise. At the same time, out‑of‑pocket costs have climbed, with nearly half of respondents paying more than $250 a month for their medication. Omada’s data suggest that when patients stay on GLP‑1 therapy for a year, they lose more weight and keep it off longer than usual. Omada’s approach blends human care teams, connected devices and AI tools to deliver personalized nutrition, exercise and medication guidance. The company claims that its 15‑year experience in virtual cardiometabolic care has helped more than a million people improve health outcomes while keeping costs down. By partnering with Lilly, Omada hopes to give employers a sustainable way to support obesity treatment and help employees achieve lasting progress. In short, this partnership expands the ways companies can provide weight‑loss support. It offers a clear cost structure for employers, more comprehensive care for patients and a chance to keep people healthier in the long run.